If you follow the standard titration, one 10 mg vial provides: Phase 1 (weeks 1 to 4 at 0.25 mg): uses 1 mg Phase 2 (weeks 5 to 8 at 0.5 mg): uses 2 mg Phase 3 (weeks 9 to 12 at 1.0 mg): uses 4 mg Total through 12 weeks: 7 mg used, 3 mg remaining Remaining 3 mg covers about 1.5 to 2 more weeks at 1.7 mg One vial
doi: 10.1016/S0005-2728(98)00167-4, 122 TaylorR
AOD-9604 is not approved by the FDA, EMA, or any other regulatory authority for any indication
S., Brcic, L., & Sebecic, B
Schematic representing experimental design for tumour induction and treatment in VillinCre ERT2
Lipotropics (Fat-Burning Nutrients) A combination of amino acids, B vitamins, and other compounds that support fat breakdown